TY - JOUR
T1 - Insomnia and suicidal ideation in nonaffective psychosis
AU - Miller, Brian J.
AU - Parker, Carmen B.
AU - Rapaport, Mark H.
AU - Buckley, Peter F.
AU - McCall, William V.
N1 - Funding Information:
Direct funding for this research was provided by the National Institute of Mental Health (NIMH; Dr. Miller). The NIMH had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. Conflict of interest statement. Dr. Miller received grant support for this study from the National Institute of Mental Health (K23MH098014). In the past 12 months, Dr. Miller also received research support from NARSAD, the Stanley Medical Research Institute, Acadia, Alkermes, and Augusta University; and Honoraria from Psychiatric Times. Dr. Parker has nothing to disclose. Dr. Rapaport has nothing to disclose relevant to the present work. In the past 12 months, Dr. Rapaport is a member of the scientific advisory board for Pax, Inc. (unpaid) and the Depression and Bipolar Alternative Therapies Foundation, and a consultant for the American Psychiatric Association. Dr. Buckley has nothing to disclose for this study. In the past 12 months, Dr. Buckley reports grants from Ameritox, grants from Auspex Pharmaceuticals, Inc., grants from Alkermes, Inc., grants from Avanir Pharmaceuticals, Inc., grants from Otsuka Pharmaceuticals, and grants and consultant support from NIMH. Dr. McCall has nothing to disclose for the work under consideration. In the past 12 months, Dr. McCall has received research support from NIMH, the American Foundation for Suicide Prevention, Merck Pharmaceuticals, and the MECTA Corporation. He has been a consultant for Multiple Energy Technologies, and Anthem Insurance. He has been a paid CME speaker for CME Outfitters.
Publisher Copyright:
© Sleep Research Society 2018. Published by Oxford University Press on behalf of the Sleep Research Society.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Study Objectives Insomnia is a common symptom in the clinical course of schizophrenia. There is a robust association between insomnia and suicidality in other psychiatric disorders. Two previous studies found associations between insomnia and suicide attempt or completed suicide in patients with schizophrenia. We hypothesized that greater insomnia would be associated with greater levels of suicidal ideation in patients with schizophrenia and other nonaffective psychoses. Methods We recruited 108 inpatients and outpatients age 18-65 between July 2010 and July 2016 with DSM-IV nonaffective psychosis (schizophrenia, schizoaffective disorder, or schizophreniform disorder). We investigated relationships between current insomnia (Insomnia Severity Index [ISI]), suicidal ideation over the past week, and lifetime history of suicide attempt (Beck Scale for Suicide Ideation [BSS]) in regression analyses. Results After controlling for potential confounders, insomnia was a significant indicator of suicidal ideation (β = 0.27, p = 0.032). Insomnia was also a significant indicator of a high BSS score (≥16; OR = 1.14, 95% CI: 1.01-1.28, p = 0.029). Furthermore, participants with severe insomnia were almost 15 times more likely to have a lifetime history suicide attempt than participants without current insomnia (OR = 14.8, 95% CI: 1.4-157, p = 0.025). Insomnia was also an indicator of greater PANSS total (β = 0.33, p = 0.001), positive subscale (β = 0.32, p = 0.002), and general subscale (β = 0.40, p < 0.001) scores. Conclusions Insomnia is associated with suicidal ideation, lifetime suicide attempt, and greater psychopathology in patients with schizophrenia. Our findings suggest that formal assessment of insomnia may be germane to the clinical care of patients with schizophrenia as a marker of suicide risk and symptom severity.
AB - Study Objectives Insomnia is a common symptom in the clinical course of schizophrenia. There is a robust association between insomnia and suicidality in other psychiatric disorders. Two previous studies found associations between insomnia and suicide attempt or completed suicide in patients with schizophrenia. We hypothesized that greater insomnia would be associated with greater levels of suicidal ideation in patients with schizophrenia and other nonaffective psychoses. Methods We recruited 108 inpatients and outpatients age 18-65 between July 2010 and July 2016 with DSM-IV nonaffective psychosis (schizophrenia, schizoaffective disorder, or schizophreniform disorder). We investigated relationships between current insomnia (Insomnia Severity Index [ISI]), suicidal ideation over the past week, and lifetime history of suicide attempt (Beck Scale for Suicide Ideation [BSS]) in regression analyses. Results After controlling for potential confounders, insomnia was a significant indicator of suicidal ideation (β = 0.27, p = 0.032). Insomnia was also a significant indicator of a high BSS score (≥16; OR = 1.14, 95% CI: 1.01-1.28, p = 0.029). Furthermore, participants with severe insomnia were almost 15 times more likely to have a lifetime history suicide attempt than participants without current insomnia (OR = 14.8, 95% CI: 1.4-157, p = 0.025). Insomnia was also an indicator of greater PANSS total (β = 0.33, p = 0.001), positive subscale (β = 0.32, p = 0.002), and general subscale (β = 0.40, p < 0.001) scores. Conclusions Insomnia is associated with suicidal ideation, lifetime suicide attempt, and greater psychopathology in patients with schizophrenia. Our findings suggest that formal assessment of insomnia may be germane to the clinical care of patients with schizophrenia as a marker of suicide risk and symptom severity.
KW - insomnia
KW - psychiatric disorders
KW - schizophrenia
KW - suicide
UR - http://www.scopus.com/inward/record.url?scp=85061478010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061478010&partnerID=8YFLogxK
U2 - 10.1093/sleep/zsy215
DO - 10.1093/sleep/zsy215
M3 - Article
C2 - 30407600
AN - SCOPUS:85061478010
SN - 0161-8105
VL - 42
JO - Sleep
JF - Sleep
IS - 2
M1 - zsy215
ER -